Global Autacoids and Related Drugs Market: Overview
Autacoids refer to the biological factors that work like hormones and are released from body cells in response to various types of stimulations to prompt physiological responses such as treatment of a local injury or other ailments. Any imbalance in the release, synthesis, or transduction system associated with these temporarily formed biological agents trigger pathological conditions such as allergy, inflammation, and hypersensitivity. Autacoids antagonists are prescribed for the prevention of such undesirable changes to the body in response to imbalance in the operation of autacoids.
This report on the global market for autacoids and related drugs presents estimates and forecasts regarding the growth prospects of the market on global, regional, and country levels. Predictions regarding the market and its key segments are provided for the period between 2016 and 2024 based on consumption value and revenue prospects, considering 2015 as the base year. The report includes a detailed value chain analysis for all the key market segments with thorough qualitative as well as quantitative data for these segments.
The report also elucidates the key factors expected to have a sizeable impact on the overall development of the global autacoid and related drugs market over the period between 2016 and 2024. As such, key drivers, restraints, trends, regulations, and vendor and competitive landscapes are analyzed. Key growth opportunities in the autacoids and related drugs market on regional as well as global levels are also analyzed in the report. The report also includes a detailed market attractiveness analysis, wherein key applications, product varieties, and region- and country-level markets have been analyzed on the basis of attractiveness for key regional markets.
Global Autacoids and Related Drugs Market: Growth Prospects
The global market for autacoids and related drugs is expected to cross the 100 bn mark by 2018. Rising research and development activities demonstrating the use of autacoids as potential therapeutic immunomodulators for a variety of disease conditions and the increased interest in use of lipid autacoids as important therapeutic agents for treating chronic pain will be the key factors driving the market. The significant rise in cases of chronic pain across the globe and the increased focus of the medical community on the severity of chronic pain and finding effective ways to treat it are expected to make lipid autacoids a key drug candidate for the condition in the near future.
Global Autacoids and Related Drugs Market: Segmentation
Autacoids are broadly segmented into polypeptides, decarboxylated amino acids, and eicosanoids. The key varieties of polypeptides in autacoids are vasopressin, angiotensin, vasoactive intestinal polypeptide, plasma kinin, slow reacting substances of anaphylaxis, and substance P. Key varieties of decarboxylated amino acids are serotonin and histamine. The key applications of autacoids and related drugs are treatment of allergies, inflammation, gastric acid secretion, neuroendocrine regulation, chronic pain, cardiovascular diseases, gastrointestinal diseases, and anaphylactic reactions.
The key drug categories related to autacoids include drugs related to lipid-derived autacoids, polypeptide autacoids, drugs related to endothelium-derived autacoids, and biogenic amines. Of these, the segment of biogenic amines is presently the dominant drug category in the autacoids class, accounting for nearly 65% of the overall autacoids market.
In terms of geography, the market has been segmented into regions such as North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Additionally, the report also includes a country-level analysis of the market for autacoids across these regions. Data included in the report combines demand and consumption statistics for key applications and product varieties across key regions and countries.
Global Autacoids and Related Drugs Market: Companies Profiled in the Report
The report provides an exhaustive competitive outlook of the market including vast details such as the share of key companies, product portfolio, business strategies, recent developments, financial overview (wherever applicable), and strengths and weaknesses of key players operating in the global autacoids and related drugs market.
Some of the key companies operating in the global autacoid and related drugs market are Bedford Laboratories, Bristol-Myers Squibb, APP Pharma, Abbott Laboratories, Sanofi-Aventis, Chattem Inc., Xanodyne, AstraZeneca, and Hospira.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.